Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,013 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changing Trends in Mechanical Circulatory Support Use and Outcomes in Patients Undergoing Percutaneous Coronary Interventions for Acute Coronary Syndrome Complicated With Cardiogenic Shock: Insights From a Nationwide Registry in Japan.
Nishimoto Y, Inohara T, Kohsaka S, Sakakura K, Kawai T, Kikuchi A, Watanabe T, Yamada T, Fukunami M, Yamaji K, Ishii H, Amano T, Kozuma K; J‐PCI Registry Investigators. Nishimoto Y, et al. Among authors: yamada t. J Am Heart Assoc. 2023 Dec 5;12(23):e031838. doi: 10.1161/JAHA.123.031838. Epub 2023 Dec 1. J Am Heart Assoc. 2023. PMID: 38038195 Free PMC article.
Effectiveness of systemic thrombolysis on clinical outcomes in high-risk pulmonary embolism patients with venoarterial extracorporeal membrane oxygenation: a nationwide inpatient database study.
Nishimoto Y, Ohbe H, Matsui H, Nakajima M, Sasabuchi Y, Sato Y, Watanabe T, Yamada T, Fukunami M, Yasunaga H. Nishimoto Y, et al. Among authors: yamada t. J Intensive Care. 2023 Feb 6;11(1):4. doi: 10.1186/s40560-023-00651-w. J Intensive Care. 2023. PMID: 36740697 Free PMC article.
β-blockers may be detrimental in frail patients with heart failure with preserved ejection fraction.
Hikoso S, Kida H, Sunaga A, Nakatani D, Okada K, Dohi T, Sotomi Y, Oeun B, Sato T, Matsuoka Y, Kitamura T, Yamada T, Kurakami H, Tamaki S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Yamada T, Yasumura Y, Sakata Y; OCVC-Heart Failure investigators. Hikoso S, et al. Among authors: yamada t. Clin Res Cardiol. 2024 Jun;113(6):842-855. doi: 10.1007/s00392-023-02301-5. Epub 2023 Nov 29. Clin Res Cardiol. 2024. PMID: 38019285
Clinical trajectories and outcomes of patients with heart failure with preserved ejection fraction with normal or indeterminate diastolic function.
Oeun B, Hikoso S, Nakatani D, Mizuno H, Kitamura T, Okada K, Dohi T, Sotomi Y, Kida H, Sunaga A, Sato T, Matsuoka Y, Kurakami H, Yamada T, Tamaki S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Yamada T, Yasumura Y, Sakata Y; OCVC-Heart Failure Investigators. Oeun B, et al. Among authors: yamada t. Clin Res Cardiol. 2023 Jan;112(1):145-157. doi: 10.1007/s00392-022-02121-z. Epub 2022 Nov 10. Clin Res Cardiol. 2023. PMID: 36357804
Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model.
Sotomi Y, Hikoso S, Nakatani D, Okada K, Dohi T, Sunaga A, Kida H, Sato T, Matsuoka Y, Kitamura T, Komukai S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Tamaki S, Ohtani T, Yasumura Y, Yamada T, Sakata Y; OCVC-Heart Failure Investigator. Sotomi Y, et al. Among authors: yamada t. Heart. 2023 Jul 27;109(16):1231-1240. doi: 10.1136/heartjnl-2022-322181. Heart. 2023. PMID: 36822821 Free PMC article.
Effect of anti-claudin 18.2 monoclonal antibody zolbetuximab alone or combined with chemotherapy or programmed cell death-1 blockade in syngeneic and xenograft gastric cancer models.
Nishibata T, Weng J, Omori K, Sato Y, Nakazawa T, Suzuki T, Yamada T, Nakajo I, Kinugasa F, Türeci Ö, Şahin U, Yoshida T. Nishibata T, et al. Among authors: yamada t. J Pharmacol Sci. 2024 Jul;155(3):84-93. doi: 10.1016/j.jphs.2024.04.004. Epub 2024 Apr 18. J Pharmacol Sci. 2024. PMID: 38797537 Free article.
ASO Visual Abstract: Results of a Randomized Clinical Study of Gemcitabine Plus Nab-Paclitaxel versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (RCT, CSGO-HBP-015).
Yamada D, Kobayashi S, Takahashi H, Iwagami Y, Akita H, Asukai K, Shimizu J, Yamada T, Tanemura M, Yokoyama S, Tsujie M, Asaoka T, Takeda Y, Morimoto O, Tomokuni A, Doki Y, Eguchi H. Yamada D, et al. Among authors: yamada t. Ann Surg Oncol. 2024 May 25. doi: 10.1245/s10434-024-15479-3. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38796587 No abstract available.
A machine learning model for predicting the lymph node metastasis of early gastric cancer not meeting the endoscopic curability criteria.
Kato M, Hayashi Y, Uema R, Kanesaka T, Yamaguchi S, Maekawa A, Yamada T, Yamamoto M, Kitamura S, Inoue T, Yamamoto S, Kizu T, Takeda R, Ogiyama H, Yamamoto K, Aoi K, Nagaike K, Sasai Y, Egawa S, Akamatsu H, Ogawa H, Komori M, Akihiro N, Yoshihara T, Tsujii Y, Takehara T. Kato M, et al. Among authors: yamada t. Gastric Cancer. 2024 May 25. doi: 10.1007/s10120-024-01511-8. Online ahead of print. Gastric Cancer. 2024. PMID: 38795251
12,013 results
You have reached the last available page of results. Please see the User Guide for more information.